| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.09 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |